These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 25265247)

  • 1. Imaging B lymphocytes in autoimmune inflammatory diseases.
    Iodice V; Laganà B; Lauri C; Capriotti G; Germano V; D'Amelio R; Picchianti Diamanti A
    Q J Nucl Med Mol Imaging; 2014 Sep; 58(3):258-68. PubMed ID: 25265247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging B lymphocytes in autoimmune inflammatory diseases.
    Iodice V; Laganà B; Lauri C; Capriotti G; Germano V; D'Amelio R; Picchianti Diamanti A
    Q J Nucl Med Mol Imaging; 2014 May; ():. PubMed ID: 24809276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging T-lymphocytes in inflammatory diseases: a nuclear medicine approach.
    Malviya G; Galli F; Sonni I; Signore A
    Q J Nucl Med Mol Imaging; 2014 Sep; 58(3):237-57. PubMed ID: 25265246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting T and B lymphocytes with radiolabelled antibodies for diagnostic and therapeutic applications.
    Malviya G; Galli F; Sonni I; Pacilio M; Signore A
    Q J Nucl Med Mol Imaging; 2010 Dec; 54(6):654-76. PubMed ID: 21221072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting monocytes and macrophages by means of SPECT and PET.
    Van De Wiele C; Sathekge M; Maes A
    Q J Nucl Med Mol Imaging; 2014 Sep; 58(3):269-75. PubMed ID: 24844256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (99m)Tc-labeled rituximab for imaging B lymphocyte infiltration in inflammatory autoimmune disease patients.
    Malviya G; Anzola KL; Podestà E; Laganà B; Del Mastro C; Dierckx RA; Scopinaro F; Signore A
    Mol Imaging Biol; 2012 Oct; 14(5):637-46. PubMed ID: 22127469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [B cells as key contributors in determining the level of immune responses -B-cell-targeted therapy in patients with autoimmune diseases].
    Kondo S; Akashi T; Katsuta H; Iwakiri R; Anzai K; Nagafuchi S; Niho Y; Harada M
    Fukuoka Igaku Zasshi; 2005 Apr; 96(4):86-92. PubMed ID: 15991605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of radiolabelled anti-TNFa monoclonal antibodies for diagnostic purposes and therapy evaluation.
    Glaudemans AW; Dierckx RA; Kallenberg CG; Fuentes KL
    Q J Nucl Med Mol Imaging; 2010 Dec; 54(6):639-53. PubMed ID: 21221071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NK cell imaging by in vitro and in vivo labelling approaches.
    Galli F; Histed S; Aras O
    Q J Nucl Med Mol Imaging; 2014 Sep; 58(3):276-83. PubMed ID: 25265248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The therapeutic potential of anti-CD20 "what do B-cells do?".
    Eisenberg R; Looney RJ
    Clin Immunol; 2005 Dec; 117(3):207-13. PubMed ID: 16169773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of pathogenic B-cell clones in antibody mediated autoimmune disorders.
    Wang J; Zhu X
    J Dermatol Sci; 2004 Dec; 36(3):141-8. PubMed ID: 15541635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting B Cells and Plasma Cells in Autoimmune Diseases.
    Hofmann K; Clauder AK; Manz RA
    Front Immunol; 2018; 9():835. PubMed ID: 29740441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug insight: the mechanism of action of rituximab in autoimmune disease--the immune complex decoy hypothesis.
    Taylor RP; Lindorfer MA
    Nat Clin Pract Rheumatol; 2007 Feb; 3(2):86-95. PubMed ID: 17299446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiopharmaceuticals for the study of inflammatory processes: a review.
    Chianelli M; Mather SJ; Martin-Comin J; Signore A
    Nucl Med Commun; 1997 May; 18(5):437-55. PubMed ID: 9194086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B-cell-directed therapy for inflammatory skin diseases.
    Nagel A; Hertl M; Eming R
    J Invest Dermatol; 2009 Feb; 129(2):289-301. PubMed ID: 19148218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SPECT radiopharmaceuticals for imaging chronic inflammatory diseases in the last decade.
    Anzola LK; Galli F; Dierckx RA
    Q J Nucl Med Mol Imaging; 2015 Jun; 59(2):197-213. PubMed ID: 25669765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic targeting of B cells for rheumatic autoimmune diseases.
    Engel P; Gómez-Puerta JA; Ramos-Casals M; Lozano F; Bosch X
    Pharmacol Rev; 2011 Mar; 63(1):127-56. PubMed ID: 21245206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B cells as a therapeutic target in autoimmune diseases other than rheumatoid arthritis.
    Looney RJ
    Rheumatology (Oxford); 2005 May; 44 Suppl 2():ii13-ii17. PubMed ID: 15851522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-CD20 monoclonal antibodies: beyond B-cells.
    Avivi I; Stroopinsky D; Katz T
    Blood Rev; 2013 Sep; 27(5):217-23. PubMed ID: 23953071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus.
    Eisenberg R; Albert D
    Nat Clin Pract Rheumatol; 2006 Jan; 2(1):20-7. PubMed ID: 16932648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.